Drug Profile
Research programme: nonsteroidal anti-inflammatory drug - Daewoong Pharmaceutical
Alternative Names: IMD6; Incrementally modified drug 6Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class Nonsteroidal anti-inflammatories
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation; Lung cancer
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Inflammation in South Korea
- 16 Jul 2016 No recent reports of development identified for research development in Lung-cancer in South Korea